Second Experimental Session in MAPS Flagship MDMA Study

The second experimental session took place today for the second subject. (Due to scheduling complications, the first subject’s second session is scheduled for next week.) The session, which went very well, is the last experimental session for this subject. She will receive some additional non-drug psychotherapy and a final follow-up evaluation two months from now.